Skip to content
Healshape logo — Restore your body through the power of self-regeneration

Healshape

Restore your body through the power of self-regeneration

Founded 2020 France France 24 employees Seed Total: $6.00M Biotechnology, 3D Printing

General Information

Company Name Healshape
Founded Year 2020
Location France France
Founders / Decision Makers
Team member Team member
Employees 24
Industries Biotechnology, 3D Printing
Funding Stage Seed
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Healshape. To contact Healshape, visit healshape.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Healshape compare?

A PDF of Healshape and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Healshape soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Healshape

Healshape, founded in 2020, is a promising player in the Biotechnology and 3D Printing industries, headquartered in France. The company positions itself as "A regenerative medicine company" aiming to revolutionize reconstructive surgery for women post-mastectomy through innovative 3D bioprinting technology.

In its short operational span, Healshape has successfully garnered investor confidence, as evidenced by a substantial €6.00M Seed Round investment completed on 28 June 2022. The funding round attracted notable investors, including Bpifrance, Demeter, Angels Santé, Crédit Agricole, Go Capital, and Win Equity.

As a pioneering firm in the high-potential field of regenerative medicine, Healshape is uniquely positioned to leverage its technological advancements for significant social impact, addressing an unmet need in restorative healthcare. This strategic vision, combined with solid financial backing, makes Healshape an attractive opportunity for investors seeking innovation-led growth within the healthcare sector.

Business keywords: Regenerative Medicine, 3D Bioprinting, Breast Regeneration, Tissue Engineering, Breast Reconstruction, Mastectomy Solutions, Tissue Engineered Products, Cell Biology, Biomedical Innovation, HealthTech, OncoTech, Regenerative Biotech, Women’s Health, Medical 3D Printing

Services & Products

Personalized Bioprostheses Development
Breast Reconstruction Solutions
Regenerative Product Research and Development

Target Customers

Breast Cancer Survivors Surgeons Specializing in Reconstructive Surgery Medical Institutions focusing on Women's Health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €6.00M 6
Bpifrance, Demeter +4
28 Jun 2022

Healshape Alternatives & Competitors

View All Alternatives
Healshape vs

Offering a scalable solution to restore lost tissue and organ function for millions of patients.

Venture round
31 employees
Biotechnology, Life Sciences
Healshape vs

Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue r...

Non Equity Assistance
24 employees
Biotechnology, Health Care
Healshape vs
CHIRON
CHIRON The Netherlands

Innovative products and solutions for the biomedical industry, regenerative medicine and drug deliv...

2-10 employees
Biotechnology, VR/AR

FAQ About Healshape

Restore your body through the power of self-regeneration
Healshape was founded in 2020.
Healshape is headquartered in France.
Healshape operates in Biotechnology and 3D Printing. Its work centres on Regenerative Medicine, 3D Bioprinting, Breast Regeneration and Tissue Engineering. Its customers include Breast Cancer Survivors, Surgeons Specializing in Reconstructive Surgery and Medical Institutions focusing on Women's Health.
Healshape has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Healshape has approximately 24 employees.
Healshape has completed 1 funding round, raising a total of $6.00M. The latest funding stage is Seed.
Healshape offers: Personalized Bioprostheses Development, Breast Reconstruction Solutions, Regenerative Product Research and Development.
Top alternatives and competitors to Healshape include Cellbricks Therapeutics, LATTICE MEDICAL, CHIRON, T&RBiofab, REGEMAT 3D. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Healshape and Cellbricks Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Healshape, https://bouncewatch.com/company/healshape, updated 24 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout